Skip to content
Abierto
Menu

Award notice

Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics

75F40124R00002-Optum-(Lewin)

Food and Drug Administration, FDA Office of Acq Grant SVCS. Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services.

View on SAM.govMarkdown

Awarded

The Lewin Group, Inc.

$75,000,000.00 on the award notice, September 26, 2024, contract 75F40124D00044

Description

As published on SAM.gov.

Multiple Award Indefinite Delivery / Indefinite Quantity (ID/IQ) contract for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), Biologics Effectiveness and Safety (BEST)

Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). $75,000,000.00 IDIQ ceiling for each contract.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
The Lewin Group, Inc.
UEI
KRVRMDJKAA16
CAGE
09UQ3
Vendor location
La Crosse, WI
Contract
75F40124D00044
Obligated
$10,000.00, potential $75,000,000
Actions
2 between September 26, 2024 and July 21, 2025
Competition
Full and Open Competition, 8 offers received
Set-aside reported
No Set Aside Used.
Described as
Center for Biologics Evaluation and Research (Cber) Requirement for Biologics Effectiveness and Safety (Best) Initiative #3: Health Care Data Sources for Surveillance of Biologics (Best 3)
Match
award number 75F40124D00044 equals the contract number; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 27, 2024

    Award notice, originally solicitation

    Awarded to THE LEWIN GROUP, Inc. La Crosse for $75,000,000. SAM.gov, notice 16e644c03fba498fb1748e3c39c1c643

Points of contact

Also open from this buyer